Does EVEROLIMUS Cause Glycosylated haemoglobin increased? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Glycosylated haemoglobin increased have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.2% of all adverse event reports for EVEROLIMUS.
60
Reports of Glycosylated haemoglobin increased with EVEROLIMUS
0.2%
of all EVEROLIMUS reports
6
Deaths
30
Hospitalizations
How Dangerous Is Glycosylated haemoglobin increased From EVEROLIMUS?
Of the 60 reports, 6 (10.0%) resulted in death, 30 (50.0%) required hospitalization.
Is Glycosylated haemoglobin increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Glycosylated haemoglobin increased?
DULAGLUTIDE (2,691)
INSULIN GLARGINE (2,649)
INSULIN LISPRO (2,482)
METFORMIN (1,539)
INSULIN HUMAN (1,008)
EXENATIDE (921)
SEMAGLUTIDE (818)
EMPAGLIFLOZIN (743)
TIRZEPATIDE (555)
INSULIN ASPART (550)
Which EVEROLIMUS Alternatives Have Lower Glycosylated haemoglobin increased Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE